Endocrine therapy (ET) is one of the standard adjuvant treatments to reduce the risk of
recurrence and mortality in patients with hormone receptor positive early breast cancer …

Methods The information presented in this invited review was derived through searching
Medline-indexed publications in the English language in the relevant topic area. Whenever …

Purpose In 2020, almost 9 million women were diagnosed with cancer worldwide. Despite
advancements in cancer treatment strategies, patients still suffer from acute and long-term …

Background Lasofoxifene, a novel endocrine therapy (ET), showed antitumor activity versus
fulvestrant in women with ESR1-mutated, metastatic breast cancer (mBC) that progressed …

Эндометриальный полип (ЭП)-частая случайная находка при гистероскопии у
бессимптомных пациенток. К настоящему времени патогенез ЭП до конца не раскрыт …

Учебное пособие содержит материалы, касающиеся терминологии,
распространенности, современных классификационных принципов, морфологии и …

Endometrial polyp (EP) is a frequent incidental finding during hysteroscopy in asymptomatic
patients. To date, the pathogenesis of EPs has not been fully disclosed, which challenges …

Aromatase inhibitors are effective drugs used in adjuvant therapy of breast cancer. Their
action is to reduce the level of oestrogens produced in adipose tissue in women in …